Loss of heterozygosity of the Wilms' tumor suppressor gene (WT1) in in situ and invasive breast carcinoma (Q77899591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Loss of heterozygosity of the Wilms' tumor suppressor gene (WT1) in in situ and invasive breast carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

A Fabre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D O'Shea

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Broderick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Keating

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

B Tobin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Gorey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P A Dervan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

661-665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10374774%20AND%20SRC:MED&resulttype=core&format=json

Insulin-like growth factors and cancer

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

The insulin-like growth factor system as a target in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Type I insulin-like growth factor receptor function in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Expression of transforming growth factor beta mRNA isoforms in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Study of tumor infiltrating lymphocytes and transforming growth factor-β as prognostic factors in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

The genomic organization and expression of the WT1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Base sequence discrimination by zinc-finger DNA-binding domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Functional properties of WT1.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

A clinical overview of WT1 gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Mutations in the Wilms' tumour gene, WT1. What do they mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Immunohistochemical studies of early breast cancer evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Hinfl polymorphism within the 3′ untranslated region of the candidate Wilms tumour gene

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Allele frequency of HinfI restriction fragment length polymorphism (RFLP) and dinucleotide repeat polymorphism in the Wilms tumor gene (WT1) among the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Analysis of genetic alterations related to the development and progression of breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990091-6

7 January 2021